Suboxone Film, Soluble
Product Images NDC 12496-1204

10 FDA label images from Indivior Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Suboxone (NDC 12496-1204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indivior Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Sub01 0048 01)

Figure (Sub01 0048 01)
Chemical structure diagram of buprenorphine hydrochloride, showing the molecular arrangement of atoms in the compound.*
FDA Label Image

Figure (Sub01 0048 02)

Figure (Sub01 0048 02)
Chemical structure of buprenorphine hydrochloride, one of the active ingredients in Suboxone film, a soluble buccal and sublingual prescription drug by Indivior Inc.*
FDA Label Image

Figure 1 (Sub01 0048 03)

Figure 1 (Sub01 0048 03)
Instructional illustration showing hands opening a foil pouch containing a Suboxone film, soluble dosage form. The images demonstrate peeling back the pouch to access the buccal or sublingual film dose from INDIVIOR INC.*
FDA Label Image

Figure 2 (Sub01 0048 04)

Figure 2 (Sub01 0048 04)
An instructional illustration showing hands opening a Suboxone soluble film packet. The first frame depicts peeling open the foil pouch, and the second frame shows using scissors to cut the pouch open. The packet label text is visible but not fully legible.*
FDA Label Image

Figure 3 (Sub01 0048 05)

Figure 3 (Sub01 0048 05)
An anatomical illustration showing the proper placement of a buccal/sublingual soluble film inside the mouth. The image depicts an open mouth with the film positioned on the inside of the lower cheek, indicating correct administration for a film dosage form such as Suboxone.*
FDA Label Image

Figure 4 (Sub01 0048 06)

Figure 4 (Sub01 0048 06)
An instructional illustration showing the administration of Suboxone soluble film. The left image depicts a person placing the film on the inside of the cheek (buccal placement) using their fingers. The right image shows the film positioned inside the mouth, indicating proper placement for dissolving.*
FDA Label Image

Principal Display Panel – 2 mg Carton Label (Sub01 0048 07)

Principal Display Panel – 2 mg Carton Label (Sub01 0048 07)
Box packaging label for Suboxone 2 mg/0.5 mg sublingual film containing buprenorphine and naloxone. The label indicates 30 pouches with one sublingual film each. It is labeled for prescription use by Indivior Inc. Instructions and safety warnings are present, including a note to keep the product out of reach of children.*
FDA Label Image

Principal Display Panel – 4 mg Carton Label (Sub01 0048 08)

Principal Display Panel – 4 mg Carton Label (Sub01 0048 08)
Packaging label for Suboxone 4 mg/1 mg sublingual film by Indivior Inc. The carton holds 30 pouches, each containing one buprenorphine and naloxone sublingual film. The label includes administration instructions, warnings, and the NDC number 12496-1204-3, with a purple and white design.*
FDA Label Image

Principal Display Panel – 8 mg Carton Label (Sub01 0048 09)

Principal Display Panel – 8 mg Carton Label (Sub01 0048 09)
The packaging label for Suboxone 8 mg/2 mg sublingual film features the brand name and generic ingredients buprenorphine and naloxone prominently. It indicates a package of 30 pouches each containing 1 sublingual film. The label includes warnings for accidental ingestion by children, advises not to cut, chew, or swallow the film whole, and is labeled for Rx only. The manufacturer is INDIVIOR INC, with a barcode and lot and expiration date sections clearly shown.*
FDA Label Image

Principal Display Panel –12 mg Carton Label (Sub01 0048 10)

Principal Display Panel –12 mg Carton Label (Sub01 0048 10)
Packaging label for Suboxone sublingual film 12 mg/3 mg by Indivior Inc., containing 30 pouches with 1 film each. The label shows the proprietary name Suboxone with the generic ingredients buprenorphine and naloxone, instructions for use, and warnings against cutting or chewing the film. The label includes barcodes, lot and expiration placeholders, and pharmacist instructions to dispense the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.